{"nct_id":"NCT00892775","title":"Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds","status":"COMPLETED","status_verified_date":"2019-10","start_date":"2009-06-03","start_date_type":"ACTUAL","primary_completion_date":"2010-09-17","primary_completion_date_type":"ACTUAL","completion_date":"2010-12-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}